Publicacións nas que colabora con Eva Poveda López (41)

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  3. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Human T-Lymphotropic Virus Infection in Hepatitis C Virus-Antibody Positive Patients in Spain

    AIDS Research and Human Retroviruses, Vol. 33, Núm. 10, pp. 1013-1017

  2. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5

2014

  1. HIV-2 and HTLV-1 infections in Spain, a non-endemic region

    AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159

  2. HIV-2 viral tropism influences CD4+ T cell count regardless of viral load

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 8, pp. 2191-2194

2013

  1. Hepatitis B, C, and D and HIV infections among immigrants from equatorial guinea living in Spain

    American Journal of Tropical Medicine and Hygiene, Vol. 88, Núm. 4, pp. 789-794

  2. Hepatitis C therapy with HCV NS5B polymerase inhibitors

    Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 9, pp. 1161-1170

  3. Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy

    Journal of Clinical Virology, Vol. 58, Núm. 2, pp. 391-395

  4. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

  5. Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

    Liver International, Vol. 33, Núm. 9, pp. 1357-1362

  6. Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

    Antiviral Therapy, Vol. 18, Núm. 8, pp. 1033-1035

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

  2. Predicted effect of direct acting antivirals in the current HIV-HCV-coinfected population in Spain

    Antiviral Therapy, Vol. 17, Núm. 3, pp. 571-575

2011

  1. A highly sensitive and specific model for predicting HIV-1 tropism in treatment-experienced patients combining interpretation of V3 loop sequences and clinical parameters

    Journal of Acquired Immune Deficiency Syndromes, Vol. 56, Núm. 1, pp. 51-58

  2. Natural polymorphisms associated with resistance to new antivirals against HCV in newly diagnosed HIV-HCV-coinfected patients

    Antiviral Therapy, Vol. 16, Núm. 3, pp. 413-416

2010

  1. Drug resistance mutations in HIV-infected patients in the Spanish drug resistance database failing tipranavir and darunavir therapy

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 3018-3020